Lv2
180 积分 2025-07-06 加入
A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics
20天前
已完结
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
27天前
已完结
Messenger interference RNA therapies targeting apolipoprotein C-III and angiopoietin-like protein 3 for mixed hyperlipidemia: the future of plozasiran and zodasiran
29天前
已完结
Homozygous familial hypercholesterolemia in China: Genetic and clinical characteristics from a real-world, multi-center, cohort study
29天前
已完结
Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3
1个月前
已完结
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials
1个月前
已完结
Systematic review with meta‐analysis: hepatitis B surface antigen decline and seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy
1个月前
已完结
Antisense oligonucleotides as drugs with both direct and indirect antiviral actions
1个月前
已完结
Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
1个月前
已完结
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
1个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
9个月前
已采纳
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
9个月前
已采纳
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
9个月前
已采纳
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
9个月前
已采纳
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
1年前
已采纳
天然低共熔溶剂提取姜黄素类化合物的研究
1年前
已采纳
皖公网安备34019202002308
